Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Saccharides >  Monosaccharide >  CIMIFUGIN BETA-D-GLUCOPYRANOSIDE

CIMIFUGIN BETA-D-GLUCOPYRANOSIDE

Basic information Safety Supplier Related

CIMIFUGIN BETA-D-GLUCOPYRANOSIDE Basic information

Product Name:
CIMIFUGIN BETA-D-GLUCOPYRANOSIDE
Synonyms:
  • CIMIFUGIN BETA-D-GLUCOPYRANOSIDE
  • 5H-Furo[3,2-g][1]benzopyran-5-one,7-[(β-D-
  • glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-,(2S)-
  • Prim-O-glucosylcimifugin, 98%, from Cimicifuga foetida L.
  • prim-O-Glucosylcimifugin
  • (2S)-2-(2-hydroxypropan-2-yl)-4-methoxy-7-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-2,3-dihydrofuro[3,2-g]chromen-5-one
  • Cimifugin 7-glucoside
  • rim-O-glucosylcimifugin
CAS:
80681-45-4
MF:
C22H28O11
MW:
468.45
Product Categories:
  • chemical reagent
  • pharmaceutical intermediate
  • phytochemical
  • reference standards from Chinese medicinal herbs (TCM).
  • standardized herbal extract
Mol File:
80681-45-4.mol
More
Less

CIMIFUGIN BETA-D-GLUCOPYRANOSIDE Chemical Properties

Melting point:
118~120℃
Boiling point:
736.9±60.0 °C(Predicted)
Density 
1.53±0.1 g/cm3(Predicted)
storage temp. 
4°C, protect from light
solubility 
DMF: 15 mg/ml; DMSO: 15 mg/ml; Ethanol: 15 mg/ml; PBS (pH 7.2): 5 mg/ml
pka
12.94±0.70(Predicted)
form 
powder to crystal
color 
White to Light yellow
InChIKey
XIUVHOSBSDYXRG-BZOGYWBENA-N
SMILES
C12=C(C=C3O[C@H](C(C)(C)O)CC3=C1OC)OC(CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=CC2=O |&1:5,19,21,24,26,28,r|
More
Less

Safety Information

Safety Statements 
24/25
HS Code 
29389090
More
Less

CIMIFUGIN BETA-D-GLUCOPYRANOSIDE Usage And Synthesis

Chemical Properties

White crystalline powder, soluble in methanol, derived from Fangji, Fangfeng, Huashan Qianhu.

Uses

Prim-O-glucosylcimifugin have anti-inflammatory, immunosuppressive effects.

Definition

ChEBI: PRIM-O-GLUCOSYLCIMIFUGIN is an organic heterotricyclic compound and an oxacycle.

in vivo

Bronchoalveolar lavage fluid (BALF) is collected at 7 h after lipopolysaccharide (LPS) administration and the cytokine levels in BALF are measured by ELISA. The levels of TNF-α, IL-1β and IL-6 in BALF are increased dramatically compared with control group. However, pretreatment with Prime-O-glucosylcimifugin (2.5, 5 or 10 mg/kg) significantly down-regulates the levels of TNF-α, IL-1β and IL-6 in a dose-dependent manner (P<0.05, P<0.01)[1].

target

COX-2

< span>

iNOS

IC 50

iNOS; COX-2

CIMIFUGIN BETA-D-GLUCOPYRANOSIDESupplier

Hubei Danding Pharmaceutical Technology Co., Ltd Gold
Tel
17701422019
Email
1559451077@qq.com
CHENGDU JINMAIRUI BIO-TECHNOLOGY CO.LTD Gold
Tel
028-83133020 18280298385
Email
1223808415@qq.com
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd Gold
Tel
17701422015
Email
3582572959@qq.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com